These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa]. Arita K, Daido K, Ohashi N, Nakamura K, Takeshima Y, Kohara T. Jpn J Antibiot; 1999 Jul; 52(7):491-6. PubMed ID: 10516928 [Abstract] [Full Text] [Related]
23. Role of OmpD2 and chromosomal beta-lactamase in carbapenem resistance in clinical isolates of Pseudomonas aeruginosa. Satake S, Yoneyama H, Nakae T. J Antimicrob Chemother; 1991 Aug; 28(2):199-207. PubMed ID: 1778851 [Abstract] [Full Text] [Related]
24. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993 [Abstract] [Full Text] [Related]
25. [Analysis of the resistance mechanism and homology of carbapenems-resistant Pseudomonas aeruginosa]. Liu Y, Deng Q, Yu Y, Cao X, Xu Q, Wan L. Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):15-20. PubMed ID: 24684984 [Abstract] [Full Text] [Related]
26. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study. Courtois N, Caspar Y, Maurin M. Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685 [Abstract] [Full Text] [Related]
27. [Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp]. Sacha P, Wieczorek P, Jakoniuk P, Zórawski M. Wiad Lek; 2008 Sep; 61(1-3):30-6. PubMed ID: 18717040 [Abstract] [Full Text] [Related]
28. [Comparative antibacterial activity of carbapenems against P. aeruginosa (1)]. Hikida M, Terashima S, Sato Y, Okamoato R, Inoue M. Jpn J Antibiot; 2001 Nov; 54(11):571-9. PubMed ID: 11828603 [Abstract] [Full Text] [Related]
29. Carbapenemase-producing Pseudomonas aeruginosa in UK. Woodford N, Palepou MF, Babini GS, Bates J, Livermore DM. Lancet; 1998 Aug 15; 352(9127):546-7. PubMed ID: 9716067 [No Abstract] [Full Text] [Related]
30. En bloc transduction of imipenem resistance with other resistance determinants from a clinical strain of Pseudomonas aeruginosa. Babálová M, Blahová J, Hupková-Lesická M, Krcméry V, Schäfer V. J Chemother; 1996 Feb 15; 8(1):43-6. PubMed ID: 8835107 [Abstract] [Full Text] [Related]
31. Resistance Pattern and Detection of Metallo-beta-lactamase Genes in Clinical Isolates of Pseudomonas aeruginosa in a Central Nigeria Tertiary Hospital. Zubair KO, Iregbu KC. Niger J Clin Pract; 2018 Feb 15; 21(2):176-182. PubMed ID: 29465051 [Abstract] [Full Text] [Related]
32. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B. APMIS; 2005 Mar 15; 113(3):187-96. PubMed ID: 15799762 [Abstract] [Full Text] [Related]
33. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study]. Cavallo JD, Leblanc F, Fabre R. Pathol Biol (Paris); 2000 Jun 15; 48(5):472-7. PubMed ID: 10949844 [Abstract] [Full Text] [Related]
34. Plasmid-Borne AFM Alleles in Pseudomonas aeruginosa Clinical Isolates from China. Chen M, Cai H, Li Y, Wang N, Zhang P, Hua X, Yu Y, Sun R. Microbiol Spectr; 2022 Oct 26; 10(5):e0203522. PubMed ID: 36000902 [Abstract] [Full Text] [Related]
35. The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre. van der Bij AK, Mol M, van Westreenen M, Goessens WH, Pitout JD. Scand J Infect Dis; 2011 Aug 26; 43(8):596-602. PubMed ID: 21506891 [Abstract] [Full Text] [Related]
36. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country. Samuelsen O, Buarø L, Giske CG, Simonsen GS, Aasnaes B, Sundsfjord A. J Antimicrob Chemother; 2008 Apr 26; 61(4):827-30. PubMed ID: 18227087 [Abstract] [Full Text] [Related]
37. Evaluation of high-level carbapenem resistance in atypical Serratia marcescens by a comparison with its revertants. Marumo K, Nagaki T, Nakamura Y. J Antimicrob Chemother; 1996 Jul 26; 38(1):47-58. PubMed ID: 8858456 [Abstract] [Full Text] [Related]
38. Activity of Ceftolozane-Tazobactam and Ceftazidime-Avibactam against Beta-Lactam-Resistant Pseudomonas aeruginosa Isolates. Humphries RM, Hindler JA, Wong-Beringer A, Miller SA. Antimicrob Agents Chemother; 2017 Dec 26; 61(12):. PubMed ID: 28993338 [Abstract] [Full Text] [Related]
39. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials. Iaconis JP, Pitkin DH, Sheikh W, Nadler HL. Clin Infect Dis; 1997 Feb 26; 24 Suppl 2():S191-6. PubMed ID: 9126693 [Abstract] [Full Text] [Related]
40. Role of cephalosporinase in carbapenem resistance of clinical isolates of Pseudomonas aeruginosa. Zhou XY, Kitzis MD, Gutmann L. Antimicrob Agents Chemother; 1993 Jun 26; 37(6):1387-9. PubMed ID: 8328794 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]